1. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1061,
1996,
Page 2-2
&NA;,
Preview
|
PDF (1131KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
2. |
Red pepper remedy for certain types of incontinence? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1061,
1996,
Page 3-4
Steve Winter,
Preview
|
PDF (2132KB)
|
|
摘要:
Intravesical administration of capsaicin, the pungent ingredient of red peppers (Capsicumspp.), has potential as a new approach for treating urinary incontinence in patients with neurological disease. The effect of capsaicin on neuronal innervation of the human bladder and the results of new clinical trials with the compound were discussed at the 26th Annual Meeting of the International Continence Society [Athens, Greece; August 1996].
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
3. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1061,
1996,
Page 4-4
&NA;,
Preview
|
PDF (1132KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
4. |
Criteria for evaluating response in chronic HCV infection |
|
Inpharma Weekly,
Volume &NA;,
Issue 1061,
1996,
Page 5-5
&NA;,
Preview
|
PDF (1012KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
5. |
Thrombolysis or angioplasty for acute MI? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1061,
1996,
Page 6-6
&NA;,
Preview
|
PDF (869KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
6. |
Aciclovir HSV prophylaxis during pregnancy reduces costs |
|
Inpharma Weekly,
Volume &NA;,
Issue 1061,
1996,
Page 7-7
&NA;,
Preview
|
PDF (1064KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
7. |
Intralesional hCG effective in Kaposi's sarcoma |
|
Inpharma Weekly,
Volume &NA;,
Issue 1061,
1996,
Page 8-8
&NA;,
Preview
|
PDF (1025KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
8. |
New drugs signal rapid growth of anti-obesity drug market |
|
Inpharma Weekly,
Volume &NA;,
Issue 1061,
1996,
Page 9-10
Gill Higgins,
Preview
|
PDF (2224KB)
|
|
摘要:
The idea of treating obesity with pharmaceutical drugs is gaining greater acceptance among the medical profession as recognition of obesity as a serious medical condition increases. Thus, a new drug market has been created that will probably be associated with multi-billion dollar sales around the world. Tetrahydrolipstatin [orlistat; Roche; phase III] and sibutramine [Knoll; preregistration] are the only 2 drugs on the verge of providing competition to currently available appetite suppressants, such as dexfenfluramine. However, a number of other drugs are further down the line, with some interesting new approaches in development. These include Neuromedica's novel dopamine D2autoreceptor agonist, NMI-8739, a drug that was featured at the 3rd IBC USA International Symposium on Obesity entitled ‘Advances in Understanding and Treatment’ [San Diego, US; September 1996].
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
9. |
Gene therapy via a transgenic epithelium? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1061,
1996,
Page 10-10
&NA;,
Preview
|
PDF (1107KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
10. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1061,
1996,
Page 11-11
&NA;,
Preview
|
PDF (1017KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|